The company
Neogen Corporation
NEOG · Nasdaq
NEOG stood above a rising 150-day average in 44 of the last 52 weekly readings, including each of the last 12 weeks. It is 13.3% above that average now. Diagnostics & Labs: 52% of its 44 stocks in an uptrend (+5 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 12 in a row
- Industry in uptrend
- 52% +5 in 4 wk
- Insider buys, 12 months
- $20K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 5
- Institutions holding
- 291 (+10)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 44 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
5 disclosed lines: House 5, Senate 0, executive 0; 3 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Greg Gianforte House: U.S. House ClerkMT00 | sold | $1k–$15k | 13 Oct 2020filed 9 Nov 2020 |
| Donna E. Shalala House: U.S. House ClerkFL27 | sold | $1k–$15k | 24 Jun 2019filed 27 Apr 2020 |
| Greg Gianforte House: U.S. House ClerkMT00 | bought | $100k–$250k | 12 Jun 2019filed 1 Jul 2019 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $1k–$15k | 7 Jan 2016filed 27 Jan 2016 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 24 Sep 2015filed 5 Oct 2015 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Mikheal NassifCEO | bought | 505at $11.95 | 9 Oct 2026filed 9 Oct 2026 |
| Mikheal NassifCEO | bought | 370at $11.81 | 4 Aug 2026filed 6 Aug 2026 |
| Mikheal NassifCEO | bought | 23at $10.94 | 17 Feb 2026filed 17 Feb 2026 |
| Mikheal NassifCEO | bought | 24at $10.00 | 2 Feb 2026filed 2 Feb 2026 |
| Mikheal NassifCEO | bought | 25at $9.86 | 26 Jan 2026filed 2 Feb 2026 |
| Mikheal NassifCEO | bought | 137at $9.33 | 16 Jan 2026filed 16 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 33,431,015$300.5M | +810,010+2.5% |
| NEUBERGER BERMAN GROUP LLCadded · filed 13 Aug 2026 | 16,570,795$149.0M | +8,819,077+113.8% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 13,038,732$117.2M | +206,468+1.6% |
| DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026 | 9,828,174$88.4M | +696,153+7.6% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 9,655,248$86.8M | +90,202+0.9% |
| ING GROEP NVadded · filed 13 Aug 2026 | 9,102,300$81.8M | +198,000+2.2% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 8,946,377$80.4M | +356,033+4.1% |
| Gates Capital Management, Inc.added · filed 14 Aug 2026 | 8,742,274$78.6M | +2,483,625+39.7% |
| Hudson Bay Capital Management LPreduced · filed 14 Aug 2026 | 6,500,000$58.4M | -1800.0% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 5,832,899$52.4M | +271,286+4.9% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.